CLO25-074: Outcomes to Immune Checkpoint Inhibitors (ICIs) According to Programmed Death-Ligand 1 (PD-L1) Levels in KRAS-, KEAP1-, STK11-Mutant Lung Squamous Cell Carcinoma (LSCC).
Justin W Shi, Ahmad Karkash, Weston He, Mya T Tran, Yan Han, Misty Dawn Shields, Julian A Marin-Acevedo
Author Information
- Justin W Shi: 1Indiana University Indianapolis, Indianapolis, IN.
- Ahmad Karkash: 1Indiana University Indianapolis, Indianapolis, IN.
- Weston He: 1Indiana University Indianapolis, Indianapolis, IN.
- Mya T Tran: 2Indiana University Health Simon Cancer Center, Indianapolis, IN.
- Yan Han: 1Indiana University Indianapolis, Indianapolis, IN.
- Misty Dawn Shields: 2Indiana University Health Simon Cancer Center, Indianapolis, IN.
- Julian A Marin-Acevedo: 2Indiana University Health Simon Cancer Center, Indianapolis, IN.
No abstract text available.
